Literature DB >> 15984502

Lymphoedema: estimating the size of the problem.

Anne F Williams1, Peter J Franks, Christine J Moffatt.   

Abstract

Lymphoedema is a problem frequently encountered by professionals working in palliative care. This article reviews the evidence on the magnitude of the problem of lymphoedema in the general population and provides evidence on specific high risk groups within it. Prevalence is a good indicator of the burden of disease for chronic problems such as lymphoedema, as it indicates the numbers of patients who require care. Incidence is indicative of changes in the causes of lymphoedema and the success of any prevention programmes. Both are important means of assessing the current level of need and the potential for the changing needs in managing this condition. Problems exist in all studies in relation to precise definitions of lymphoedema, inconsistent measures to assess differential diagnosis and poorly defined populations. While there is some evidence of high rates in relation to breast cancer therapy, the total burden of lymphoedema in the general population is largely unknown.

Entities:  

Mesh:

Year:  2005        PMID: 15984502     DOI: 10.1191/0269216305pm1020oa

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  27 in total

1.  Possible genetic predisposition to lymphedema after breast cancer.

Authors:  Beth Newman; Felicity Lose; Mary-Anne Kedda; Mathias Francois; Kaltin Ferguson; Monika Janda; Patsy Yates; Amanda B Spurdle; Sandra C Hayes
Journal:  Lymphat Res Biol       Date:  2012-03-09       Impact factor: 2.589

2.  Risk factors for lymphedema after breast cancer treatment.

Authors:  Sandra A Norman; A Russell Localio; Michael J Kallan; Anita L Weber; Heather A Simoes Torpey; Sheryl L Potashnik; Linda T Miller; Kevin R Fox; Angela DeMichele; Lawrence J Solin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-26       Impact factor: 4.254

3.  Randomised controlled trial to determine the benefit of daily home-based exercise in addition to self-care in the management of breast cancer-related lymphoedema: a feasibility study.

Authors:  Eunice Jeffs; Theresa Wiseman
Journal:  Support Care Cancer       Date:  2012-10-17       Impact factor: 3.603

4.  The impact of lower limb chronic oedema on patients' quality of life.

Authors:  Adelene Greene; Pauline Meskell
Journal:  Int Wound J       Date:  2016-08-04       Impact factor: 3.315

5.  Prevalence of lymphoedema and quality of life among patients attending a hospital-based wound management and vascular clinic.

Authors:  Georgina Gethin; Danielle Byrne; Sean Tierney; Helen Strapp; Seamus Cowman
Journal:  Int Wound J       Date:  2011-09-13       Impact factor: 3.315

6.  Lymphangiogenesis-independent resolution of experimental edema.

Authors:  Emily L Ongstad; Echoe M Bouta; Jaclynn E Roberts; Joseph S Uzarski; Sara E Gibbs; Michael S Sabel; Vincent M Cimmino; Melissa A Roberts; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-05       Impact factor: 4.733

7.  Change in extracellular fluid and arm volumes as a consequence of a single session of lymphatic massage followed by rest with or without compression.

Authors:  J Maher; K Refshauge; L Ward; R Paterson; S Kilbreath
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

8.  The challenges of managing complex lymphoedema/chronic oedema in the UK and Canada.

Authors:  Philip A Morgan; Susie Murray; Christine J Moffatt; Amanda Honnor
Journal:  Int Wound J       Date:  2011-08-17       Impact factor: 3.315

9.  The experience of patients with lymphoedema undergoing a period of compression bandaging in the UK and Canada using the 3M™ Coban™ 2 compression system.

Authors:  Philip A Morgan; Susie Murray; Christine J Moffatt; Helen Young
Journal:  Int Wound J       Date:  2011-08-17       Impact factor: 3.315

Review 10.  Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema.

Authors:  Yeliz Cemal; Sarah Jewell; Claudia R Albornoz; Andrea Pusic; Babak J Mehrara
Journal:  Lymphat Res Biol       Date:  2013-03       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.